Azzopardi phenomenon
Azzopardi phenomenon is a histopathological entity observed in certain types of cancer, particularly lung cancer and gastric cancer. It is named after the pathologist George Azzopardi who first described it in 1973.
Overview[edit]
The Azzopardi phenomenon is characterized by the presence of necrosis (cell death) and hemorrhage (bleeding) in the walls of blood vessels within a tumor. This is accompanied by the deposition of DNA from dead tumor cells on the walls of these blood vessels. The DNA appears as a dark, smudgy material under the microscope, a feature that is characteristic of the Azzopardi phenomenon.
Clinical Significance[edit]
The Azzopardi phenomenon is a significant finding in the diagnosis of certain types of cancer. It is particularly associated with small cell lung cancer and gastric adenocarcinoma, but can also be seen in other types of cancer. The presence of the Azzopardi phenomenon can help pathologists to differentiate between different types of tumors and can provide important information about the aggressiveness of the tumor.
History[edit]
The Azzopardi phenomenon was first described by the Maltese pathologist George Azzopardi in 1973. He observed this phenomenon in a series of lung cancer cases and noted its potential diagnostic significance. Since then, the Azzopardi phenomenon has been reported in a variety of other cancers and has become a well-recognized feature in the field of pathology.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
